Ultrasound guided foam sclerotherapy: Factors associated with outcomes and complications

European Journal of Vascular and Endovascular Surgery

Volumn 40, Issue 3, 2010, Pages 389-392

  Thomasset, S C ^a   Butt, Z ^a   Liptrot, S ^a   Fairbrother, B J ^a   Makhdoomi, K R ^a  

^a KING S MILL HOSPITAL   (United Kingdom)

Author keywords

Complications; Foam; Outcomes; Sclerotherapy; Varicose vein

Indexed keywords

SCLEROSING AGENT;

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GENDER; GROUPS BY AGE; HUMAN; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; PAIN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; SAPHENOUS VEIN; SCLEROTHERAPY; SKIN DISCOLORATION; THROMBOPHLEBITIS; TREATMENT OUTCOME; ULTRASOUND GUIDED FOAM SCLEROTHERAPY; VARICOSIS; VEIN SURGERY;

EID: 84859165365     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.04.007     Document Type: Article

References (19)

1. Winterborn RJ, Corbett CR. Treatment of varicose veins: The present and the futureea questionnaire survey. Ann R Coll Surg Engl 2008;90:561-4.
2. Orbach EJ, Petretti AK. The thrombogenic property of foam of a synthetic anionic detergent (sodium tetradecyl sulfate N.N.R.). Angiology 1950;1:237-43.
3. Cabrera Garrido J, Cabrera Garcia-Olmedo JR, Garcia-Olmedo Dominguez MA. Elargissement des limites de la sclerotherapy: Nouveaux produits sclerosants. Phlebologie 1997;50:181-8.
4. Monfreux A. Treatement sclerosant des troncs sapheneis et leurs collaterales e gros calibre par le methode MUS. Phlebologie 1997;50:351-3.
5. Tessari L. Nouvelle technique d'obtention de la sclero-mousse. Phebologie 2000;53:129-33.
6. Coleridge-Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006;32:577-83.
7. Darke GS, Baker SJA. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins. British Journal of Surgery 2006;93:969-74. (Pubitemid 44214847)
8. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasoundguided sclerotherapy for varicose veins: Medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 2007;33:116-21. (Pubitemid 44872674)
9. Myers KA, Jolley D. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 2008;36:602-5.
10. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830-6.
11. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007; 94:925-36. (Pubitemid 47236534)
12. Guex J-J, Allaert F-A, Gillet J-L, Chleir F. Immediate and midterm complications of sclerotherapy: Report of a prospective multicentre registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005;31:124-8.
13. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162-4. (Pubitemid 43083525)
14. Bergan J, Pascarella L, Mekenas L. Venous disorders: Treatment with sclerosant foam. J Cardiovasc Surg 2006;47:9-18.
15. Cabrera J, Redondo P, Becerra A, Garrido C, Cabrera Jr. J, Garcia-Olmedo MA, et al. Ultrasound-guided injection of polidocanol microfoam in the management of venous leg ulcers. Arch Dermatol 2004;140:667-73. (Pubitemid 38747281)
16. Rao J, Wildemore JK, Goldman MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 2005;31:631-5. (Pubitemid 43093412)
17. Ceulen RP, Bullens-Goessens YI, Pi-VAN DE Venne SJ, Nelemans PJ, Veraart JC, Sommer A. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: Results of a randomized controlled trial with 1-year follow-up. Dermatol Surg 2007;33:276-81. (Pubitemid 46328226)
18. Hamel-Desnos C, Ouvry P, Benigni JP, Boitelle G, Schadeck M, Desnos P, et al. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: A randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study". Eur J Vasc Endovasc Surg 2007;34:723-9. (Pubitemid 350056378)
19. Breu FX, Guggenbichler S, Wollmann JC. 2nd European consensus meeting on foam sclerotherapy 2006, Tegernsee, Germany. Vasa 2008;71:1-29.